Phase
Condition
Diabetes Prevention
Diabetes And Hypertension
Diabetes Mellitus Types I And Ii
Treatment
Medtronic 780G insulin pump
Clinical Study ID
Ages 7-19 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
The subject is age 7-19
The subject with one or more of the below
serum c-peptide ≤ 0.6 ng/mL at diagnosis
positive glutamic acid decarboxylase (GAD) antibody
positive islet cell antibody
positive anti-Insulin antibody
positive anti-islet Antigen-2 (IA-2) antibody
The subject was diagnosed with type 1 diabetes ≥ 1 year
The subject has been continuously treated at least for 8 weeks at the start of thestudy, by one of the existing insulin treatment methods [insulin multi-injection (MDII), general insulin pump (CSII), sensor-linked insulin pump (SAP), or 770Ginsulin pump (HCL system)]
The subject has been applied with real-time continuous glucose monitoring at leastfor 8 weeks at the start of the study
Exclusion
Exclusion Criteria:
Any systemic treatment with drugs known to interfere with glucose metabolism within 8 weeks prior to trial
Subjects with underlying hematologic disorders that can affect the HbA1c levels
Subjects with underlying medical disorders that can affect glucose metabolism
Subjects with a neuropsychiatric disorder such as depression or eating disorder
Subjects with underlying thyroid disorders and abnormal thyroid function
Study Design
Study Description
Connect with a study center
Seoul National University Hospital
Seoul, 03080
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.